I think Hypi is talking about filling the gap this week. We will not get good news this week (I mean the kind of news driving our pps far away from the gap).
That being said, 1.50$ may be the bottom so it could be we fill the gap by some quick dip (because of the TA guys all looking at that gap).
In the second part of this week we may have the Judges decision in the PPHM vs CSM request of CSM to limit the damages amount to a maximum before the trial starts.
Whatever the outcome is it will hardly do anything to the pps, unless maybe a few little trading moves, but certainly not something fundamental.
The market is since long not counting on any revenue out of that trial to be of major importance for PPHM. Whatever they get will just be a bonus now that they have that much cash on the bank.
The real catalysts will be NSCLC events (be it early stop or 1st look in), Liver results, Breast results with peer-reviewed paper.
In the category surprise news some Yervoy+Bavi Immuno IST Melanoma early results could be explosive.
Furthermore an OFFICIAL confirmation of the 3 Doctors that independently observed prolonged immunity against cancer after Bavi treatment, and this as well in Chemo (Breast IST) , Radio (pre-clinical) and Immuno (pre-clinical with Yervoy), that this is not an observation by change will be a game changer on top of the past game changer resulting in the new MOA. We may see a NEW MOA update in the next 24 months.
News 
Market Data 
Discover 
